Antibody treatment halts aggressive prostate cancer in early trials
A newly developed antibody has halted the growth and spread of aggressive prostate cancer in preclinical tests, raising hopes for a more targeted way of treating metastatic disease without the side effects that have…
Read on Refractor ↗